FDA Adverse Event Malfunction Summary report: N

COAGUCHEK ® XS SYSTEM

MDR report key: 6192669 · Received December 21, 2016

Report

Report Number
1823260-2016-02029
Event Type
Malfunction
Date Received
December 21, 2016
Date of Event
December 7, 2016
Report Date
January 6, 2017
Manufacturer
ROCHE DIAGNOSTICS
Product Code
GJS
PMA / PMN Number
K062925
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

THE CUSTOMER RETURNED THE METER AND TEST STRIPS. THE RETURNED METER AND STRIPS WERE TESTED IN COMPARISON TO A RETENTION METER & MASTERLOT STRIPS. TWO HUMAN BLOOD SAMPLES FROM WARFARIN DONORS AND INTERNAL REFERENCE METERS WERE USED. DONOR #1 HCT: 42%, DONOR #2 HCT: 47%. DONOR #1 MASTER LOT: 2.4 INR, DONOR #1 CUSTOMER'S STRIPS AND CUSTOMER'S METER: 2.5 INR. DONOR #2 MASTER LOT: 3.8 INR, DONOR #2 CUSTOMER'S STRIPS AND CUSTOMER'S METER: 3.8 INR. ALL INR VALUES WERE WITHIN THE SPECIFIED MAXIMUM DIFFERENCE BETWEEN MEASUREMENTS. NO ERROR MESSAGES OCCURRED. THE RETURNED MATERIAL AND THE RETENTION MATERIAL MEET THE SPECIFICATION. RELEVANT RETENTION TEST STRIPS (LOT 128043-21) WERE TESTED IN COMPARISON WITH THE CURRENT MASTER LOT COAGUCHEK XS PT TEST STRIP (LOT 124158-80). FOR THIS PURPOSE TWO HUMAN BLOOD SAMPLES FROM MARCUMAR DONORS AND TWO INTERNAL REFERENCE METERS WERE USED. NO ERROR MESSAGES OCCURRED. RETENTION MATERIAL WAS ACCEPTABLE.

Description of Event or Problem · 1

THE CUSTOMER COMPLAINED OF ERRONEOUS INR RESULTS ON HIS COAGUCHEK XS METER WITH SERIAL NUMBER (B)(4) WHEN COMPARED TO THE LABORATORY USING THE DADE INNOVIN METHOD. THE CUSTOMER TESTED ON HIS METER AT EITHER 10:31 A.M. OR 11:31 A.M. AND OBTAINED A RESULT OF 2.6 INR. THE QC CHECK MARK WAS OBSERVED FOR THIS TEST. THE CUSTOMER WAS TESTED "WITHIN MINUTES" ON THE DOCTOR¿S NON-ROCHE METER AND THE RESULT WAS 3.8 INR. THE CUSTOMER HAD A RESULT OF 3.5 INR FROM THE LABORATORY USING THE DADE INNOVIN METHOD. THE SAMPLE WAS OBTAINED "WITHIN MINUTES" OF THE FINGER STICK RESULT FROM THE CUSTOMER¿S METER. THE DOCTOR ADJUSTED THE CUSTOMER¿S WARFARIN DOSE BASED ON THE 3.5 INR RESULT FROM THE LABORATORY. THE CUSTOMER HAD BEEN ADVISED TO NOT TAKE WARFARIN FOR 1 DAY BASED ON A RESULT OF 4.3 INR FROM THE LABORATORY ON (B)(6) 2016. THE CUSTOMER¿S THERAPEUTIC RANGE IS 2-3 INR. NO ADVERSE EVENT OCCURRED. THE CUSTOMER IS FEELING FINE. THE CUSTOMER IS NOT ON HEPARIN OR DIRECT THROMBIN INHIBITORS. THE CUSTOMER HAS NO ANTIPHOSPHOLIPID ANTIBODIES. THE CUSTOMER IS NOT TAKING ANY NEW MEDICATIONS AND HAS HAD NO CHANGES IN DIET. THE CUSTOMER HAS HAD NO ADDITIONAL ILLNESSES AND IS NOT EXPERIENCING ANY BLEEDING OR BRUISING. THE METER AND STRIPS WERE REQUESTED FOR INVESTIGATION. REPLACEMENTS WERE SENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
843987 COAGUCHEK ® XS SYSTEM PROTHROMBIN TIME TEST STRIPS GJS ROCHE DIAGNOSTICS NA 12804321

Patients

Seq Age Sex Outcome Treatment
1 76 YR WARFARIN